All (2)News (2)Transcripts (0)Press Releases (0)

News17 days ago

Tandem Diabetes Shares Rebound Amid Legal Actions

Tandem Diabetes Care shares are trading higher amid anticipation of a favorable resolution following a securities class action investigation.

News110 days ago

Tandem Diabetes Care Faces Multiple Downgrades

Tandem Diabetes Care shares are trading lower following a series of downgrades from several firms. Piper Sandler downgraded its price target to $14.00, RBC to $25.00, TD Cowen to $20.00, Jefferies to $45.00, and Leerink Partners to $32.00.